Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clear-cell Renal Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00002764
What this trial is testing

Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma

Who this might be right for
Endometrial CancerKidney CancerMetastatic Cancer+3 more
European Organisation for Research and Treatment of Cancer - EORTC 340
Testing effectiveness (Phase 2)Study completedNCT00323739
What this trial is testing

Bevacizumab (Avastin) and RAD001(Everolimus)in the Treatment of Advanced Clear Cell Renal Carcinoma

Who this might be right for
Kidney Cancer
SCRI Development Innovations, LLC 80
Testing effectiveness (Phase 2)Study completedNCT00688753
What this trial is testing

RAPTOR: RAD001 as Monotherapy in the Treatment of Advanced Papillary Renal Cell Tumors Program in Europe

Who this might be right for
CarcinomaRenal CellNon Clear Cell Renal Carcinoma+2 more
Novartis Pharmaceuticals 92
Testing effectiveness (Phase 2)Study completedNCT03163667
What this trial is testing

CB-839 With Everolimus vs. Placebo With Everolimus in Participants With Renal Cell Carcinoma (RCC)

Who this might be right for
Clear Cell Renal Cell Carcinoma
Calithera Biosciences, Inc 69
Not applicableStudy completedNCT06791863
What this trial is testing

Visceral Fat Area as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma: A Multicenter Study on Postoperative Survival

Who this might be right for
ccRCC
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 1,030
Very early researchStudy completedNCT01221506
What this trial is testing

Pazopanib/DCE-MRIs in Renal Cell Carcinoma (RCC)

Who this might be right for
Carcinoma, Renal Cell
Abramson Cancer Center at Penn Medicine 20
Testing effectiveness (Phase 2)Study completedNCT02960906
What this trial is testing

A BIOmarker Driven Trial With Nivolumab and Ipilimumab or VEGFR tKi in Naïve Metastatic Kidney Cancer

Who this might be right for
Clear Cell Metastatic Renal Cell Carcinoma
Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie 200
Testing effectiveness (Phase 2)Study completedNCT03693612
What this trial is testing

GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid Tumors

Who this might be right for
Neoplasms
GlaxoSmithKline 26
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06730932
What this trial is testing

A Prospective，Single Arm, Multicenter Clinical Study of BTLA Monoclonal Antibody JS004 (B/T Lymphocyte Attenuator Factor Monoclonal Antibody) in Combination With Toripalimab in Patients With Unresectable or Advanced Renal Cell Carcinoma Who Had Failed Previous Immunotherapy

Who this might be right for
Unresectable or Advanced Clear Cell Renal Cell Carcinoma That Has Progressed After Previous Immunotherapy
RenJi Hospital 31
Testing effectiveness (Phase 2)Looking for participantsNCT06852638
What this trial is testing

CD70-targeted immunoPET Imaging of Malignant Cancers

Who this might be right for
Renal CancerRenal Clear Cell CarcinomaLymphoma+4 more
RenJi Hospital 300
Testing effectiveness (Phase 2)Looking for participantsNCT07386158
What this trial is testing

Pucotenlimab Combination With Vorolanib as Neoadjuvant Therapy for ccRCC

Who this might be right for
VorolanibClear Cell Renal Cell Carcinoma (ccRCC)Neoadjuvant Therapy
Sun Yat-sen University 21
Testing effectiveness (Phase 2)Study completedNCT01538238
What this trial is testing

Pazopanib_NCRCC,Ph2 STUDY

Who this might be right for
Locally Advanced or Metastatic Non-clear Cell Type Renal Cell Carcinoma
Samsung Medical Center 10
Testing effectiveness (Phase 2)Study completedNCT01798446
What this trial is testing

A Phase II Study of Axitinib in Metastatic Non-clear Cell Renal Cell Carcinoma Patients Previously Treated With Temsirolimus

Who this might be right for
Renal Cell CarcinomaNonclear CellTemsirolimus Resistance
Seoul National University Hospital 41
Not applicableLooking for participantsNCT06349642
What this trial is testing

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

Who this might be right for
Early Stage Triple-Negative Breast CarcinomaMetastatic Bladder Urothelial CarcinomaMetastatic Cervical Carcinoma+24 more
Mayo Clinic 324
Early research (Phase 1)Looking for participantsNCT07187869
What this trial is testing

Modulation of the Bone Immune Microenvironment Following Cabozantinib Treatment of Bone Metastatic Clear Cell Renal Cell Carcinoma: Proof of Concept Study

Who this might be right for
Clear Cell Renal Cell Carcinoma
M.D. Anderson Cancer Center 16
Not applicableNo Longer AvailableNCT06090331
What this trial is testing

89Zr-DFO-girentuximab Expanded Access Program (EAP)

Who this might be right for
Clear Cell Renal Cell Carcinoma
Telix Pharmaceuticals (Innovations) Pty Limited
Testing effectiveness (Phase 2)Study completedNCT02724878
What this trial is testing

Study of Atezolizumab + Bevacizumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma

Who this might be right for
Advanced Non-Clear Cell Kidney Cancer
Dana-Farber Cancer Institute 65
Testing effectiveness (Phase 2)UnknownNCT05879497
What this trial is testing

68Ga-NY104 PET/CT in Patients With Metastasis/Recurrence Clear Cell Renal Cell Carcinoma Suspicion

Who this might be right for
Clear Cell Renal Cell Carcinoma
Peking Union Medical College Hospital 40
Testing effectiveness (Phase 2)Ended earlyNCT03875313
What this trial is testing

Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors

Who this might be right for
Solid TumorClear Cell Renal Cell CarcinomaTNBC - Triple-Negative Breast Cancer+4 more
Calithera Biosciences, Inc 33
Testing effectiveness (Phase 2)Active Not RecruitingNCT05148546
What this trial is testing

Neoadjuvant Study With Combination Immuno-oncology for Primary Clear Cell Renal Cell Cancer

Who this might be right for
Renal Cell Carcinoma
The Netherlands Cancer Institute 69
Next Page